Sandu Pharmaceuticals Approves Key Board Appointments at 41st AGM
Sandu Pharmaceuticals Ltd 路 Change in Management 路 12 Sept 2026, 9:46 pm
Sandu Pharmaceuticals Approves Key Board Appointments at 41st AGM Sandu Pharmaceuticals Limited announced that shareholders approved key board appointments at the 41st AGM on 11th Sep'26. Shri Balram Viswanathan has been redesignated as Chairman and Managing Director for a 3-year term effective 11th Jul'26. Additionally, Dr. Neeti Madan Kapre has been appointed as a Non-Executive Independent Director for a 5-year term, effective 11th Jul'26, not liable to retire by rotation. Neither appointee is related to any director, key managerial personnel, or promoter, nor debarred by SEBI.
Original exchange filing (PDF)
More announcements from Sandu Pharmaceuticals Ltd
- statement of deviation and variation of funds for q ended 30th sept 2026 路 15 Nov 2026
- Results for Q and half year ended 30th sept 2026 路 15 Nov 2026
- Outcome of the Board Meeting dated 14th November 2026 路 15 Nov 2026
- Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Approval of Unaudited .... 路 14 Nov 2026
- Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta 路 09 Oct 2026
- Intimation to the holders of Physical Securities to furnish PAN and KYC details 路 30 Sept 2026
- Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting 路 12 Sept 2026
- 41st Annual General Meeting scrutinizers Report 路 12 Sept 2026
